B+L completes Technolas acquisition


Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

The new collaboration will be known as Bausch + Lomb Technolas and will continue developing and commercializing surgical laser technology for ophthalmology.

B+L purchased all outstanding shares of Technolas in November 2012 to expand the company's product portfolio into cataract and refractive surgery. The companies have been co-promoting the Victus femtosecond laser, which received marketing approval in Europe in late 2011. Technolas is also developing the Supracor for the treatment of presbyopia.

John Barr, executive president of B+L, commented, "Technolas Perfect Vision’s unique laser platforms will enhance our ability to grow the business and augment our new product pipeline with cutting-edge surgical technology. We are pleased to welcome the Technolas Perfect Vision team to Bausch + Lomb and are committed to a seamless transition as we continue to provide physicians with systems, instruments and intraocular lenses that improve patients’ sight worldwide."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.